BIOAVAILABILITY OF CITRATE FROM 2 DIFFERENT PREPARATIONS OF POTASSIUM CITRATE

被引：13

作者：

HARVEY, JA

ZOBITZ, MM

PAK, CYC

机构：

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 29卷 / 04期

关键词：

D O I：

10.1002/j.1552-4604.1989.tb03338.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：338 / 341

页数：4

共 9 条

[1]

BISAZ S, 1978, MINER ELECTROL METAB, V1, P74

[2]

KOK DJ, 1986, LANCET, V1, P1056

[3]

MEYER JL, 1975, INVEST UROL, V13, P36

[4] LOW URINARY CITRATE EXCRETION IN NEPHROLITHIASIS [J].

NICAR, MJ ;

SKURLA, C ;

SAKHAEE, K ;

PAK, CYC .

UROLOGY, 1983, 21 (01) :8-14

[5]

NICAR MJ, 1987, J BONE MINER RES, V2, P215

[6]

PAK CYC, 1982, CONTRIB NEPHROL, V33, P136

[7]

PAK CYC, 1983, T ASSOC AM PHYSICIAN, V96, P294

[8] AUGMENTATION OF RENAL CITRATE EXCRETION BY ORAL POTASSIUM CITRATE ADMINISTRATION - TIME COURSE, DOSE FREQUENCY SCHEDULE, AND DOSE-RESPONSE RELATIONSHIP [J].

PAK, CYC ;

SKURLA, C ;

BRINKLEY, L ;

SAKHAEE, K .

JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (01) :19-26

[9] CONTRASTING EFFECTS OF POTASSIUM CITRATE AND SODIUM-CITRATE THERAPIES ON URINARY CHEMISTRIES AND CRYSTALLIZATION OF STONE-FORMING SALTS [J].

SAKHAEE, K ;

NICAR, M ;

HILL, K ;

PAK, CYC .

KIDNEY INTERNATIONAL, 1983, 24 (03) :348-352

← 1 →